Amgen Net Income From Continuing Ops from 2010 to 2026
| AMG Stock | 310.20 22.80 7.93% |
Net Income From Continuing Ops | First Reported 2019-03-31 | Previous Quarter 1.4 B | Current Value 3.2 B | Quarterly Volatility 727.2 M |
Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen's main balance sheet or income statement drivers, such as Tax Provision of 443.7 M, Interest Income of 218.9 M or Interest Expense of 3.8 B, as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
Amgen | Net Income From Continuing Ops |
The evolution of Net Income From Continuing Ops for Amgen Inc provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Amgen compares to historical norms and industry peers.
Latest Amgen's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Amgen Inc over the last few years. It is Amgen's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Amgen Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 6,557,884,967 | |
| Geometric Mean | 6,209,729,264 | |
| Coefficient Of Variation | 27.80 | |
| Mean Deviation | 1,427,560,630 | |
| Median | 7,722,000,000 | |
| Standard Deviation | 1,823,058,194 | |
| Sample Variance | 3323541.2T | |
| Range | 6.4B | |
| R-Value | (0.56) | |
| Mean Square Error | 2447606.1T | |
| R-Squared | 0.31 | |
| Significance | 0.02 | |
| Slope | (200,871,678) | |
| Total Sum of Squares | 53176658.9T |
Amgen Net Income From Continuing Ops History
About Amgen Financial Statements
Amgen shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Amgen investors may analyze each financial statement separately, they are all interrelated. The changes in Amgen's assets and liabilities, for example, are also reflected in the revenues and expenses on on Amgen's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 3.7 B | 5 B |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Amgen Stock Analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.